Home Your basket
• Speech disorders, verbal ...
   Price 10.50 €
• ...
   Price 5.50 €
• Delayed facial palsy afte...
   Price 8.50 €
• Percutaneous gastrostomy ...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• A protocol for post-opera...
   Price 5.50 €
• Reconstruction after hemi...
   Price 14.00 €
• A survey of current wound...
   Price 5.50 €
• Traditional and emerging ...
   Price 10.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Laryngeal tracheal post-i...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Acinic cell carcinoma in ...
   Price 8.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• «Mini-rhinoplasty»...
   Price 10.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Malignant mixed tumor of ...
   Price 5.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Plastic surgery indicatio...
   Price 10.50 €
• Endoscopic sphenoid proce...
   Price 8.50 €
• Bilateral cochlear implan...
   Price 5.50 €
• A post-styloid mass revea...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Correlation between the r...
   Price 12.50 €
• TRT: Results after one ye...
   Price 10.50 €
• Retropharyngeal abscess i...
   Price 10.50 €
• Acoustic neuroma surgery....
   Price 10.50 €
• Therapeutic management of...
   Price 10.50 €
• Dysphagia, a geriatric po...
   Price 8.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• Prospective study on 43 s...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Auditory screening in neo...
   Price 8.50 €
• Unilateral endolymphatic ...
   Price 10.50 €
• Universal hearing screeni...
   Price 10.50 €

Total Order 324.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

PAEDIATRICS

Universal hearing screening in the Champagne-Ardenne regions: Results and consideration after 55 000 births from January 2004 to June 2007


Authors : Langagne T, Schmidt P, Leveque M, Chays A. (Reims)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:153-158.

Article published in french
Downloadable PDF document french



Summary : Aim: This study presents the results of the Universal Newborn Hearing Screening (UNHS) experience in Champagne-Ardenne from January 2004 to June 2007. Materials and methods: A UNHS program was introduced in the entire French region of Champagne-Ardenne in January 2004. Developed upon a strong demand from public and private medical institutions, the program’s aim is the early detection and treatment of bilateral profound or severe hearing loss. The program is composed of 2 steps: the first test is realised in maternity and consists of automated OtoAcoustic Emissions (aOAE). When absent in both ears at first test (positive screening test), the child is referred to a second test 15 days after maternity discharge (aOAE or automated Auditory Brainstem Response (aABR)). If the second test is still failed (positive screening test), the child is referred to a diagnostic procedure (Auditory Brainstem Response) realised by a paediatrician ENT in a reference centre. The UNHS program differs for newborns in Neonatal Intensive Care Units where aABR is realised at first test because of the high frequency of auditory neuropathy in this population. All results are collected in the Regional Neonatal Screening Centre, in charge of the UNHS follow-up. Results: 53 930 newborns benefited from the UNHS program, which represent 98.7% of the 54 790 births in the region during this period. 591 newborns had a positive first test (no aOAE responses) and were referred to the second test. 532 had a negative second test and 46 had a positive second test. 22 children could not have the second test: 4 children deceased, 9 were lost to follow-up (the families moved outside the region) and 9 families refused the second test. The 46 neonates were referred to the diagnostic ABR test and 42 of those 46 babies were diagnosed with neonatal bilateral hearing losses before the age of 6 months. Conclusion: This UNHS experience demonstrates that such UNHS programs are feasible and reliable, at least in a region as wide as Champagne-Ardenne. It achieved to diagnose 42 hearing impaired children, who could benefit from an early intervention for their handicap.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE